Hostname: page-component-745bb68f8f-mzp66 Total loading time: 0 Render date: 2025-01-29T23:59:34.540Z Has data issue: false hasContentIssue false
  • English
  • Français

Which Strategies Follow From the Surveillance of Multidrug-Resistant Bacteria to Strengthen the Control of Their Spread? A French Experience

Published online by Cambridge University Press:  02 January 2015

Didier Lepelletier ,
Stéphanie Perron ,
Hélène Huguenin ,
Monique Picard ,
Pascale Bemer ,
Jocelyne Caillon ,
Marie-Emmanuelle Juvin  and
Henri Bernard Drugeon
Didier Lepelletier*
Affiliation:
Laboratoire de Bactériologie, Virologie, Hygiène Hospitalière, Hôpital G&R Laënnec, Nantes, France
Stéphanie Perron
Affiliation:
Laboratoire de Bactériologie, Virologie, Hygiène Hospitalière, Hôpital G&R Laënnec, Nantes, France
Hélène Huguenin
Affiliation:
Laboratoire de Bactériologie, Virologie, Hygiène Hospitalière, Hôpital G&R Laënnec, Nantes, France
Monique Picard
Affiliation:
Laboratoire de Bactériologie, Virologie, Hygiène Hospitalière, Hôpital G&R Laënnec, Nantes, France
Pascale Bemer
Affiliation:
Laboratoire de Bactériologie, Virologie, Hygiène Hospitalière, Hôpital G&R Laënnec, Nantes, France
Jocelyne Caillon
Affiliation:
Laboratoire de Bactériologie, Virologie, Hygiène Hospitalière, Hôpital G&R Laënnec, Nantes, France
Marie-Emmanuelle Juvin
Affiliation:
Laboratoire de Bactériologie, Virologie, Hygiène Hospitalière, Hôpital G&R Laënnec, Nantes, France
Henri Bernard Drugeon
Affiliation:
Laboratoire de Bactériologie, Virologie, Hygiène Hospitalière, Hôpital G&R Laënnec, Nantes, France
*
Laboratoire de Bactériologie, Virologie, Hygiène Hospitalière, Hôpital Laënnec, CHU Nantes, France
Get access Rights & Permissions [Opens in a new window]

Abstract

Efforts to enhance standard precautions and to isolate patients with positive routine clinical cultures during 3 years were insufficient to decrease multidrug-resistant bacteria infection rates. Routine screening for carriage in high-risk patients may be necessary to hait transmission and control the hospital reservoir.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 25 , Issue 2 , February 2004 , pp. 162 - 164
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.National Technical Nosocomial Infections Committee. Control of the Spread of Multidrug-Resistant Bacteria: Hospital Recommendations. Paris: Employment and Solidarity Ministry; 1999.Google Scholar
2.Boyce, JM. Strategies for controlling methicillin-resistant Staphylococcus aureus in hospitals. J Chemother 1995;7:81–85.Google ScholarPubMed
3.Jernigan, JA, Titus, MG, Groschel, DH, Getchell-White, S, Farr, BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996;143:496–504.CrossRefGoogle ScholarPubMed
4.Muto, CA, Jernigan, JA, Ostrowsky, BE, et al.SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362–386.CrossRefGoogle ScholarPubMed
5.Pittet, D, Safran, E, Harbarth, S, et al.Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: role of a hospital information System. Infect Control Hosp Epidemiol 1996;17:496–502.CrossRefGoogle ScholarPubMed
6.Girou, E, Pujade, G, Legrand, P, Cizeau, F, Brun-Buisson, C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemie MRSA. Clin Infect Dis 1998;27:543–550.CrossRefGoogle Scholar
7.Lucet, JC, Chevret, S, Durand-Zaleski, I, Chastang, C, Regnier, B. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: resuit of a multicenter study. Arch Intern Med 2003;163:181–188.CrossRefGoogle Scholar
8.Marshall, C, Harrington, G, Wolfe, R, Fairley, CK, Wesselingh, S, Spelman, D. Acquisition of methicillin-resistant Staphylococcus aureus in a large intensive care unit. Infect Control Hosp Epidemiol 2003;24:314–316.CrossRefGoogle Scholar
9.Ho, PL, Hong Kong Intensive Care Unit Antimicrobial Resistance Study (HK-ICARE) Group. Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant gram-negative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission. Crit Care Med 2003;31:1175–1182.Google Scholar
10.Garrouste-Orgeas, M, Timsit, JF, Kallel, H, et al.Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use. Infect Control Hosp Epidemiol 2001;22:687–692.Google Scholar
11.Theaker, C, Ormond-Walshe, S, Azadian, B, Soni, N. MRSA in the critically ill. J Hosp Infect 2001;48:98–102.CrossRefGoogle ScholarPubMed
12.Troillet, N, Carmeli, Y, Samore, MH, et al.Carriage of methicillin-resistant Staphylococcus aureus at hospital admission. Infect Control Hosp Epidemiol 1998;19:181–185.CrossRefGoogle ScholarPubMed
13.Chaix, C, Durand-Zaleski, I, Alberti, C, Brun-Buisson, C. Control of endemie methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282:1745–1751.Google Scholar
14.Papia, G, Louis, M, Tralla, A, Johnson, C, Collins, V, Simor, AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999;20:473–477.Google Scholar
15.Karchmer, TB, Durbin, LJ, Simonton, BM, Farr, BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002;51:126–132.CrossRefGoogle ScholarPubMed